Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsA European source told AFP on Tuesday that a vaccine could be authorized for use in the EU in "early 2021", after the announcement that US pharmaceutical group Pfizer and Germany's BioNTech's vaccine had shown 90 percent effectiveness in phase three trials.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.